Suppr超能文献

通过阻断CD28与其天然配体B7/BB1的相互作用诱导人T淋巴细胞中的同种抗原特异性低反应性。

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.

作者信息

Tan P, Anasetti C, Hansen J A, Melrose J, Brunvand M, Bradshaw J, Ledbetter J A, Linsley P S

机构信息

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

出版信息

J Exp Med. 1993 Jan 1;177(1):165-73. doi: 10.1084/jem.177.1.165.

Abstract

The specificity of T lymphocyte activation is determined by engagement of the T cell receptor (TCR) by peptide/major histocompatibility complexes expressed on the antigen-presenting cell (APC). Lacking costimulation by accessory molecules on the APC, T cell proliferation does not occur and unresponsiveness to subsequent antigenic stimulus is induced. The B7/BB1 receptor on APCs binds CD28 and CTLA-4 on T cells, and provides a costimulus for T cell proliferation. Here, we show that prolonged, specific T cell hyporesponsiveness to antigenic restimulation is achieved by blocking the interaction between CD28 and B7/BB1 in human mixed leukocyte culture (MLC). Secondary T cell proliferative responses to specific alloantigen were inhibited by addition to the primary culture of monovalent Fab fragments of anti-CD28 monoclonal antibody (mAb) 9.3, which block interaction of CD28 with B7/BB1 without activating T cells. Hypo-responsiveness was also induced in MLC by CTLA4Ig, a chimeric immunoglobulin fusion protein incorporating the extracellular domain of CTLA-4 with high binding avidity for B7/BB1. Cells previously primed could also be made hyporesponsive, if exposed to alloantigen in the presence of CTLA4Ig. Maximal hyporesponsiveness was achieved in MLC after 2 d of incubation with CTLA4Ig, and was maintained for at least 27 d after removal of CTLA4Ig. Accumulation of interleukin 2 (IL-2) and interferon gamma but not IL-4 mRNA was blocked by CTLA4Ig in T cells stimulated by alloantigen. Antigen-specific responses could be restored by addition of exogenous IL-2 at the time of the secondary stimulation. Addition to primary cultures of the intact bivalent anti-CD28 mAb 9.3, or B7/BB1+ transfected CHO cells or exogenous IL-2, abrogated induction of hyporesponsiveness by CTLA4Ig. These data indicate that interaction of CD28 with B7/BB1 during TCR engagement with antigen is required to maintain T cell competence and that blocking such interaction can result in a state of T cell hyporesponsiveness.

摘要

T淋巴细胞激活的特异性取决于抗原呈递细胞(APC)上表达的肽/主要组织相容性复合物与T细胞受体(TCR)的结合。由于缺乏APC上辅助分子的共刺激,T细胞不会发生增殖,并会诱导其对后续抗原刺激无反应。APC上的B7/BB1受体与T细胞上的CD28和CTLA-4结合,并为T细胞增殖提供共刺激。在此,我们表明,通过在人混合淋巴细胞培养(MLC)中阻断CD28与B7/BB1之间的相互作用,可实现对抗原再刺激的长时间、特异性T细胞低反应性。抗CD28单克隆抗体(mAb)9.3的单价Fab片段添加到原代培养物中,可抑制对特异性同种异体抗原的二次T细胞增殖反应,该片段可阻断CD28与B7/BB1的相互作用而不激活T细胞。CTLA4Ig(一种嵌合免疫球蛋白融合蛋白,包含对B7/BB1具有高结合亲和力的CTLA-4细胞外结构域)也可在MLC中诱导低反应性。如果在CTLA4Ig存在的情况下暴露于同种异体抗原,先前致敏的细胞也可变得低反应性。与CTLA4Ig孵育2天后,MLC中可达到最大低反应性,并且在去除CTLA4Ig后至少维持27天。在同种异体抗原刺激的T细胞中,CTLA4Ig可阻断白细胞介素2(IL-2)和干扰素γ而非IL-4 mRNA的积累。在二次刺激时添加外源性IL-2可恢复抗原特异性反应。完整的二价抗CD28 mAb 9.3、B7/BB1 + 转染的CHO细胞或外源性IL-2添加到原代培养物中,可消除CTLA4Ig诱导的低反应性。这些数据表明,在TCR与抗原结合期间,CD28与B7/BB1的相互作用是维持T细胞活性所必需的,并且阻断这种相互作用可导致T细胞低反应性状态。

相似文献

引用本文的文献

1
Research progress of CD80 in the development of immunotherapy drugs.CD80 在免疫治疗药物发展中的研究进展。
Front Immunol. 2024 Nov 7;15:1496992. doi: 10.3389/fimmu.2024.1496992. eCollection 2024.
6
Gene Polymorphisms in Patients with Rheumatoid Arthritis.类风湿关节炎患者的基因多态性。
Int J Environ Res Public Health. 2020 May 5;17(9):3214. doi: 10.3390/ijerph17093214.
9
Impact of infection on transplantation tolerance.感染对移植耐受的影响。
Immunol Rev. 2019 Nov;292(1):243-263. doi: 10.1111/imr.12803. Epub 2019 Sep 19.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验